Germán Bou Arévalo

Title: Germán Bou Arévalo: Innovator in Vaccine Development

Introduction

Germán Bou Arévalo is a notable inventor based in A Coruña, Spain. He has made significant contributions to the field of vaccine development, particularly through his innovative methods for producing live attenuated bacterial strains.

Latest Patents

Germán Bou Arévalo holds two patents, with his latest focusing on live attenuated vaccines. This invention refers to a method for the production of live attenuated bacterial strains that are suitable as vaccine candidates. The process involves providing a bacterial strain capable of expressing glutamate racemase and possibly D-amino acid transaminase, followed by the inactivation of the genes encoding these enzymes. This inactivation results in a bacterial strain that is auxotrophic for D-glutamate, making it a potential candidate for vaccine development.

Career Highlights

Throughout his career, Germán has worked with various organizations, including the Servicio Galego De Saúde (Sergas) and Fundación Profesor Novoa Santos. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Germán has collaborated with several professionals in his field, including María Clara Póvoa Cabral and Astrid Pérez Gómez. These collaborations have enriched his research and fostered innovation in vaccine development.

Conclusion

Germán Bou Arévalo is a distinguished inventor whose work in live attenuated vaccines has the potential to impact public health significantly. His innovative methods and collaborations highlight his commitment to advancing vaccine technology.